Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001924173 | SCV002199468 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2021-08-07 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine with threonine at codon 227 of the FOXP3 protein (p.Lys227Thr). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and threonine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FOXP3-related conditions. This variant is not present in population databases (ExAC no frequency). |